Module 1q
PrEP users
July 2017
Module 11: PrEP users. This module provides information for people who are interested in taking PrEP to reduce their risk of acquiring HIV and people who are already taking PrEP – to support them in their choice and use of PrEP. This module gives ideas for cou...ntries and organizations implementing PrEP to help them develop their own tools.
more
"This is the final report of the six-year collaboration between the WHO Department of Mental Health and Substance Abuse and the Gulbenkian Global Mental Health Platform, an initiative of the Calouste Gulbenkian Foundation aimed at reducing the global burden of mental health through the development a...nd application of evidence and good practices to global mental health."
more
Accessed on 29.01.2020
La volonté du CEA-SAMEF à développer des programmes de formation de qualité et des domaines de compétences ciblées a rendu nécessaire l’adoption de référentiels aux exigences internationales. Dans la mise en œuvre de son programme d’accréditation, le CEA-SA...MEF a procédé à l’alignement de son offre de formation aux référentiels nationaux, régionaux et internationaux, de façon à rendre éligibles les programmes à l’accréditation.
more
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...am-negative bacteria, such as Klebsiella pneumoniae and Escherichia coli, can cause severe and often deadly infections that pose a particular threat for people with weak or not yet fully developed immune systems, including newborns, ageing populations, people undergoing surgery and cancer treatment.
The report highlights a worrying gap in activity against the highly resistant NDM-1 (New Delhi metallo-beta-lactamase 1), with only three antibiotics in the pipeline. NDM-1 makes bacteria resistant to a broad range of antibiotics, including those from the carbapenem family, which today are the last line of defence against antibiotic-resistant bacterial infections.
more
Statement
Impact of migration on infectious diseases in Europe | August 2007 | 1-7
Der Globale Aktionsplan für ein gesundes Leben und das Wohlergehen aller Menschen und der Prozess zur Neuformulierung der Strategie der Bundesregierung zu Globaler Gesundheit
Myanmar’s transition to a market‐based economy is accompanied by rapid development of the private manufacturing sector, which has large potential for improving economic growth. The overall success of the sector, however, should not be taken for granted. Future advances will greatly depend on th...e policy and business environment in which manufacturing activities take place. It is, therefore, important to better understand the business environment and help inform policies conducive to sustainable economic growth.
more
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
en collaboration avec des experts en santé mentale du Centre Neuro-Psychopathologique de l’Université de Kinshasa (CNPP/UNIKIN)
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of... neglected tropical diseases, Guinea worm disease is on the verge of eradication, and 12 member states are within reach of being certified as having eradicated yaws by the end of this year.
more